|
08:20~08:30 |
Opening Remarks |
김덕경 회장 (성균관의대) |
08:30~10:00 |
Symposium I: Autophagy and Atherosclerosis |
좌장: 박영배 (서울의대),박경수 (서울의대) |
08:30~08:50 |
Autophagy overview and its role in vascular biology |
이용호 (연세의대) |
08:50~09:10 |
The regulation of autophagy and ROS axis in fatty liver disease |
배수한 (연세의대) |
09:10~09:30 |
The Role of Peroxiredoxins in Autophagic Flux in the Pathogenesis of Atherosclerosis |
오구택 (이화여대) |
09:30~09:50 |
Molecular mechanism of Parkin/PINK1-mediated mitochondrial degradation via autophagy pathway |
Koji Yamano (Tokyo Metropolitan Institute of Medical Science) |
09:50-10:10 |
discussion |
패널: 김재택, 한진, 조경현, 조정현 |
10:10-10:20 |
Break |
10:20~11:10 |
Keynote Lecture |
좌장 : 김덕경 회장 (성균관의대)
|
A novel link between inhibition of angiogenesis and tolerance to vascular stress
|
Yasufumi Sato (Tohoku Univ.) |
11:10~12:40 |
Symposium II: Nutrition session: Nutrition and Atherosclerosis |
좌장: 서홍석 (고려의대), 김양하 (이화여대) |
11:10~11:35 |
Dietary cholesterol and cardio-metabolic health |
양수진 (서울여대) |
11:35~12:00 |
What You Eat Matters to Your Grandchildren - Epigenetic Inheritance |
박윤정 (이화여대)
|
12:00~12:25 |
From feast to famine: biology and pharmacology of fibroblast growth factor 1 |
서재명 (카이스트) |
12:25~12:40 |
discussion |
패널: 김오연, 김혜진, 정창희 |
12:40~14:20 |
Scientific session |
14:20~15:50 |
Symposium III: Lessons learned from recent CV outcome trials |
좌장: 신현호 (단국의대),김치정 (중앙의대) |
Part I: Lessons learned from CV outcome trials using new anti-diabetic therapy |
14:20~14:40 |
CV outcome trials of incretin therapy (SAVOR-TIMI 53,EXAMINE, TECOS, ELIXA) |
김성래 (가톨릭의대) |
14:40~15:00 |
Cardiovascular outcome of SGLT2i (EMPA-REG OUTCOME)
|
조영민 (서울의대) |
Part II: Lessons learned from CV outcome trials using LDL-C-lowering medications |
15:00~15:20 |
High-intensity statin |
한기훈 (울산의대) |
15:20~15:40 |
Statin+Ezetimibe |
김상현 (서울의대) |
15:40~16:00 |
discussion |
패널: 김병진, 송기호, 서지아, 조상호 |
16:00~16:10 |
Break |
16:10~17:40 |
Symposium IV: Special Debate Session “Would the measurement of surrogate markers of subclinical atherosclerosis (hsCRP, coronary artery calcium score) provide additional diagnostic value for the re-allocation of subjects with intermediate cardiovascular risk?” |
16:10~16:20 |
Introduction |
이문규 (성균관의대) |
16:20~16:45 |
Pros |
성기철 (성균관의대) |
16:45~17:10 |
Cons |
김신곤 (고려의대) |
17:10~17:40 |
discussion |
패널: 이해영, 박성하, 최소연, 김대중, 권혁상 |
서울시 마포구 독막로 320 태영데시앙 1706호
TEL : 02-3272-5330 FAX : 02-3272-5331 EMAIL : ksla@lipid.or.kr
|
|